Furthermore, PD-L1 expression can be up-regulated in tumor cells that are resistant to chemotherapeutic agents (Shen et al., 2019; Wu et al., 2021), including tumor-targeting drugs such as EGFR-TKI (Peng et al., 2019), thus promoting immune escape of tumor cells. This evidence concerns the gene EGFR and neoplasm.